Current perspectives on the diagnosis and management of fatigue in multiple sclerosis
O Marchesi, C Vizzino, M Filippi… - Expert Review of …, 2022 - Taylor & Francis
Introduction Fatigue is a common and debilitating symptom among multiple sclerosis (MS)
patients with a prevalence up to 81% and with a considerable impact on quality of life …
patients with a prevalence up to 81% and with a considerable impact on quality of life …
Approach to symptom management in multiple sclerosis with a focus on wellness
R Spain - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
Approach to Symptom Management in Multiple Sclerosis With a... : CONTINUUM: Lifelong
Learning in Neurology Account Register Activate Subscription Help Subscribe American …
Learning in Neurology Account Register Activate Subscription Help Subscribe American …
The quality of life in patients with multiple sclerosis–Association with depressive symptoms and physical disability: A prospective and observational study
A Kołtuniuk, B Pawlak, D Krówczyńska… - Frontiers in …, 2023 - frontiersin.org
Background Patients with multiple sclerosis (MS) experience disabilities which significantly
affect their quality of life (QOL) and mental health. Mood disorders and depressive symptoms …
affect their quality of life (QOL) and mental health. Mood disorders and depressive symptoms …
[HTML][HTML] Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence …
JL Frederiksen, L Massacesi, HH Nielsen, A Rini… - Multiple Sclerosis and …, 2025 - Elsevier
Background Alemtuzumab is approved in the European Union for treating highly active
relapsing-remitting multiple sclerosis (RRMS). Patient-reported outcomes measure the …
relapsing-remitting multiple sclerosis (RRMS). Patient-reported outcomes measure the …
Effects of fasting and a ketogenic diet on neuropsychiatric outcomes in multiple sclerosis patients–a randomized controlled trial
LS Bahr - 2022 - refubium.fu-berlin.de
Einleitung: Multiple Sklerose (MS) ist die häufigste nichttraumatische Erkrankung des
zentralen Nervensystems bei jungen Erwachsenen. Neuropsychiatrische Symptome …
zentralen Nervensystems bei jungen Erwachsenen. Neuropsychiatrische Symptome …
[HTML][HTML] The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial
Y Sadeqi, SM Baghbanian, A Bazi… - Current Journal of …, 2022 - ncbi.nlm.nih.gov
Background: Fatigue is a common complication associated with multiple sclerosis (MS). The
aim of this study was to evaluate the impact of dalfampridine and amantadine on fatigue in …
aim of this study was to evaluate the impact of dalfampridine and amantadine on fatigue in …
[HTML][HTML] The “Journey” of Patients with Multiple Sclerosis in Greece—A Qualitative Study
Background: Multiple Sclerosis (MS) affects sufferers' lives and requires everyday efforts to
manage its challenges. Aim: The aim of this study was to explore MS patients' lived …
manage its challenges. Aim: The aim of this study was to explore MS patients' lived …
[HTML][HTML] Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials
T Boehmeke - Cureus, 2024 - ncbi.nlm.nih.gov
After a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
approximately 10-20% of patients are affected by the post-COVID syndrome (PCS). This …
approximately 10-20% of patients are affected by the post-COVID syndrome (PCS). This …
A primer Sjögren-szindróma pszichológiai vonatkozásai= Psychological features of primary Sjogren syndrome
L Módis, A Szántó, A Bugán - Orvosi hetilap, 2021 - real.mtak.hu
Primary Sjogren syndrome (pSS) is a chronic, autoimmune disorder. Primary symptoms are
ocular and oral dryness as a of an autoimmune process affecting the exocrine glands. The …
ocular and oral dryness as a of an autoimmune process affecting the exocrine glands. The …
Etiologija, patogeneza i terapija umora u multiploj sklerozi
L Bašić - 2023 - zir.nsk.hr
Sažetak Multipla skleroza (MS) je kronična, autoimuna, demijelinizacijska bolest središnjeg
živčanog sustava (SŽS). Pojava umora u oboljelih od MS-a vrlo je čest klinički entitet s …
živčanog sustava (SŽS). Pojava umora u oboljelih od MS-a vrlo je čest klinički entitet s …